Transformation to Small Cell Lung Cancer of Pulmonary Adenocarcinoma: Clinicopathologic Analysis of Six Cases

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are considered the first line treatment for a subset of EGFR-mutated non-small cell lung cancer (NSCLC) patients. Although transformation to small cell lung cancer (SCLC) is one of the known mechanisms of resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Soomin, Hwang, Soo Hyun, Han, Joungho, Choi, Yoon-La, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju, Park, Woong-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963973/
https://www.ncbi.nlm.nih.gov/pubmed/27160687
http://dx.doi.org/10.4132/jptm.2016.04.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963973/
https://www.ncbi.nlm.nih.gov/pubmed/27160687
http://dx.doi.org/10.4132/jptm.2016.04.19

Ejemplares similares